383 related articles for article (PubMed ID: 35844357)
1. The Role of Belimumab in Systemic Lupus Erythematosis: A Systematic Review.
Joy A; Muralidharan A; Alfaraj M; Shantharam D; Cherukuri ASS; Muthukumar A
Cureus; 2022 Jun; 14(6):e25887. PubMed ID: 35844357
[TBL] [Abstract][Full Text] [Related]
2. Belimumab: review of use in systemic lupus erythematosus.
Boyce EG; Fusco BE
Clin Ther; 2012 May; 34(5):1006-22. PubMed ID: 22464040
[TBL] [Abstract][Full Text] [Related]
3. Belimumab for systemic lupus erythematosus.
Singh JA; Shah NP; Mudano AS
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD010668. PubMed ID: 33631841
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of biologic therapies for systemic lupus erythematosus treatment: systematic review and meta-analysis.
Borba HH; Wiens A; de Souza TT; Correr CJ; Pontarolo R
BioDrugs; 2014 Apr; 28(2):211-28. PubMed ID: 24190520
[TBL] [Abstract][Full Text] [Related]
5. Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus.
Urowitz MB; Aranow C; Asukai Y; Bass DL; Bruce IN; Chauhan D; Dall'Era M; Furie R; Fox NL; Gilbride JA; Hammer A; Ginzler EM; Gonzalez-Rivera T; Levy RA; Merrill JT; Quasny H; Roth DA; Stohl W; van Vollenhoven R; Wallace DJ; Petri M
Arthritis Care Res (Hoboken); 2022 Nov; 74(11):1822-1828. PubMed ID: 35439360
[TBL] [Abstract][Full Text] [Related]
6. Efficacy, pharmacokinetic and pharmacodynamic profile of belimumab for systemic lupus erythematosus.
Jordan NP; D'Cruz DP
Expert Opin Drug Metab Toxicol; 2015; 11(10):1635-45. PubMed ID: 26327145
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of belimumab in central nervous system demyelinating syndromes with systemic lupus erythematosus: A case series.
Liu Y; Fan Q; Jia C; Wan Q; Yang H
Medicine (Baltimore); 2023 Jun; 102(25):e34079. PubMed ID: 37352070
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial.
van Schaik M; Arends EJ; Soonawala D; van Ommen E; de Leeuw K; Limper M; van Paassen P; Huizinga TWJ; Toes REM; van Kooten C; Rotmans JI; Rabelink TJ; Teng YKO
Trials; 2022 Nov; 23(1):939. PubMed ID: 36371234
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of belimumab therapy in systemic lupus erythematosus: A systematic review and meta-analysis.
Chiang HY; Guo ZA; Wu TW; Peng TR
Lupus; 2022 May; 31(6):666-673. PubMed ID: 35321609
[TBL] [Abstract][Full Text] [Related]
10. 10 Years of belimumab experience: What have we learnt?
Levy RA; Gonzalez-Rivera T; Khamashta M; Fox NL; Jones-Leone A; Rubin B; Burriss SW; Gairy K; Maurik AV; Roth DA
Lupus; 2021 Oct; 30(11):1705-1721. PubMed ID: 34238087
[TBL] [Abstract][Full Text] [Related]
11. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.
Furie R; Petri M; Zamani O; Cervera R; Wallace DJ; Tegzová D; Sanchez-Guerrero J; Schwarting A; Merrill JT; Chatham WW; Stohl W; Ginzler EM; Hough DR; Zhong ZJ; Freimuth W; van Vollenhoven RF;
Arthritis Rheum; 2011 Dec; 63(12):3918-30. PubMed ID: 22127708
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of belimumab therapy in lupus nephritis: a systematic review and meta-analysis.
Zhang H; Chen J; Zhang Y; Zhao N; Xu D
Ren Fail; 2023 Dec; 45(1):2207671. PubMed ID: 37194710
[TBL] [Abstract][Full Text] [Related]
13. Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol.
Teng YKO; Bruce IN; Diamond B; Furie RA; van Vollenhoven RF; Gordon D; Groark J; Henderson RB; Oldham M; Tak PP
BMJ Open; 2019 Mar; 9(3):e025687. PubMed ID: 30898822
[TBL] [Abstract][Full Text] [Related]
14. Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus Erythematosus.
Iaccarino L; Bettio S; Reggia R; Zen M; Frassi M; Andreoli L; Gatto M; Piantoni S; Nalotto L; Franceschini F; Larosa M; Fredi M; Punzi L; Tincani A; Doria A
Arthritis Care Res (Hoboken); 2017 Jan; 69(1):115-123. PubMed ID: 27390293
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of biologics in childhood systemic lupus erythematosus: a critical systematic review.
Elshaer R; Jaber S; Odeh N; Arbili L; Al-Mayouf SM
Clin Rheumatol; 2024 Mar; 43(3):863-877. PubMed ID: 38079010
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus : A Randomized Controlled Trial.
Shipa M; Embleton-Thirsk A; Parvaz M; Santos LR; Muller P; Chowdhury K; Isenberg DA; Doré CJ; Gordon C; Ehrenstein MR;
Ann Intern Med; 2021 Dec; 174(12):1647-1657. PubMed ID: 34698499
[TBL] [Abstract][Full Text] [Related]
17. Systematic review, and meta-analysis of steroid-sparing effect, of biologic agents in randomized, placebo-controlled phase 3 trials for systemic lupus erythematosus.
Oon S; Huq M; Godfrey T; Nikpour M
Semin Arthritis Rheum; 2018 Oct; 48(2):221-239. PubMed ID: 29426575
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous and intravenous belimumab in the treatment of systemic lupus erythematosus: a review of data on subcutaneous and intravenous administration.
Poh YJ; Baptista B; D'Cruz DP
Expert Rev Clin Immunol; 2017 Oct; 13(10):925-938. PubMed ID: 28847197
[TBL] [Abstract][Full Text] [Related]
19. Organ system improvements in Japanese patients with systemic lupus erythematosus treated with belimumab: A subgroup analysis from a phase 3 randomized placebo-controlled trial.
Tanaka Y; Bass D; Chu M; Egginton S; Ji B; Roth D
Mod Rheumatol; 2020 Mar; 30(2):313-320. PubMed ID: 31199180
[No Abstract] [Full Text] [Related]
20. The Safety and Efficacy of Rituximab and Belimumab in Systemic Lupus Erythematosus: A Systematic Review.
Abid N; Manaye S; Naushad H; Cheran K; Murthy C; Bornemann EA; Kamma HK; Alabbas M; Elashahab M
Cureus; 2023 Jun; 15(6):e40719. PubMed ID: 37485087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
